Stock Research for APDN


Featured Broker: Ally Invest

Get the due diligence for another stock.


APDN Stock Chart & Research Data

The APDN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the APDN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


APDN Due diligence Resources & Stock Charts

The APDN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View APDN Detailed Price Forecast - CNN Money CNN View APDN Detailed Summary - Google Finance
Yahoo View APDN Detailed Summary - Yahoo! Finance Zacks View APDN Stock Research & Analysis -

Stock Analysis

TradeIdeas View APDN Trends & Analysis - Trade-Ideas Barrons View APDN Major Holders - Barrons
NASDAQ View APDN Call Transcripts - NASDAQ Seeking View APDN Breaking News & Analysis - Seeking Alpha
Spotlight View APDN Annual Report - OTC Report View APDN OTC Short Report -
TradeKing View APDN Fundamentals - TradeKing Charts View APDN SEC Filings - Bar Chart
WSJ View Historical Prices for APDN - The WSJ Morningstar View Performance/Total Return for APDN - Morningstar
MarketWatch View the Analyst Estimates for APDN - MarketWatch CNBC View the Earnings History for APDN - CNBC
StockMarketWatch View the APDN Earnings - StockMarketWatch MacroAxis View APDN Buy or Sell Recommendations - MacroAxis
Bullish View the APDN Bullish Patterns - American Bulls Short Pains View APDN Short Pain Metrics -

Social Media Mentions

StockTwits View APDN Stock Mentions - StockTwits PennyStocks View APDN Stock Mentions - PennyStockTweets
Twitter View APDN Stock Mentions - Twitter Invest Hub View APDN Investment Forum News - Investor Hub
Yahoo View APDN Stock Mentions - Yahoo! Message Board Seeking Alpha View APDN Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for APDN - Insider Cow View Insider Transactions for APDN - Insider Cow
CNBC View APDN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for APDN - OTC Markets
Yahoo View Insider Transactions for APDN - Yahoo! Finance NASDAQ View Institutional Holdings for APDN - NASDAQ

Stock Charts

FinViz View APDN Stock Insight & Charts - StockCharts View APDN Investment Charts -
BarChart View APDN Stock Overview & Charts - BarChart Trading View View APDN User Generated Charts - Trading View

Latest Financial News for APDN

Applied DNA Sciences, Inc. (NASDAQ:APDN) Insiders Increased Their Holdings
Posted on Friday March 01, 2019

It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that there are more than a few examplesRead More...

Applied DNA Subsidiary LineaRx and Takis/Evvivax Progress Linear DNA for Use as Cancer Vaccine Candidates
Posted on Friday March 01, 2019

Applied DNA Sciences Inc. (APDN) (“Applied DNA”), a leader in large-scale PCR-based DNA manufacturing, announced today that LineaRx, Inc. (“LineaRx”), its wholly-owned subsidiary focused on next-generation biotherapeutics, will ship TK7 and ConTRT amplicons to Takis/Evvivax next week as part of the companies’ Joint Development Agreement (“JDA”) entered into in September 2018. Per the JDA, LineaRx and Takis/Evvivax will jointly develop linear DNA expression amplicons for TK7 and ConTRT, two of Takis/Evvivax’s anti-cancer vaccine candidates, utilizing LineaRx’s validated linear DNA technology. Linear DNA amplicons carrying the DNA sequences for Takis/Evvivax vaccine candidates will be delivered to pre-clinical animal models via Takis/Evvivax’s proprietary electroporation technology.

Applied DNA Signs Term Sheet with TheraCann International for Exclusive License of CertainT® Platform in Legal Cannabis and Hemp
Posted on Tuesday February 12, 2019

Applied DNA Sciences Inc. (APDN) (“Applied DNA,” or “the Company”), a leader in PCR-based DNA manufacturing for product authenticity and traceability solutions, and TheraCann International Benchmark Corporation (“TheraCann”), a leading global full-service legal cannabis and hemp consultancy, announced today that they have entered into a non-binding Term Sheet (the “Term Sheet”) for a long term exclusive licensing agreement for the use of Applied DNA’s proprietary CertainT® supply chain integrity platform technology within TheraCann’s ETCH BioTrace® seed-to-sale tracking system. The Term Sheet is expected to be followed by a definitive agreement (the “Agreement”).

Edited Transcript of APDN earnings conference call or presentation 7-Feb-19 9:30pm GMT
Posted on Monday February 11, 2019

Q1 2019 Applied DNA Sciences Inc Earnings Call

Stock Market & Investing Books

Enter a stock symbol to view the stock details.